Medical Patent Broker 500 px Logo with white letters and transparent backgroundMedical Patent Broker 500 px Logo with white letters and transparent backgroundMedical Patent Broker 500 px Logo with white letters and transparent backgroundMedical Patent Broker 500 px Logo with white letters and transparent background
  • HOME
  • FAQs
  • BLOG
  • SUBMIT LISTING/OFFER
  • EXPERTS DIRECTORY
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Patents
  • All
  • 505(b)(2)
  • Advertising
  • AI
  • alternative path
  • application
  • artificial intelligence
  • Asset Protection
  • automation
  • Backup Plan
  • board of directors
  • Business strategy
  • Buyers
  • cdc
  • CDC impact
  • CEO
  • Chemistry
  • Clinical Trials
  • CMS
  • Combinations
  • competition
  • creativity
  • deadlines
  • debt
  • Divesting
  • documents
  • Due Diligence
  • escrow
  • extending a patent
  • FDA
  • FDA Approval
  • financial impact
  • Grants
  • GRAS
  • history
  • Hold
  • How-to
  • Income
  • ingenuity
  • Innovation
  • institutional path
  • invention
  • Investing
  • investment strategy
  • IP Ownership
  • IP Strategy
  • IRS
  • Juggling
  • License
  • loan
  • market value
  • Marketing
  • Medicaid
  • Medical devices
  • medical patent
  • Medical Patents
  • Medicare
  • multiple patents
  • orphan drugs
  • Patent
  • Patent Licensing
  • Patent Maestro
  • Patent Strategy
  • patents
  • Patients
  • phase III
  • Phase IV
  • planning
  • Pre-Patent testing
  • problems
  • Process
  • profit
  • Remaining Patent Term
  • risk management
  • ROI
  • Sell
  • Sellers
  • stock split
  • stocks
  • Strategy
  • Supply Chain
  • tax
  • time
  • Timing
  • Transfers
  • value
  • All
  • admin
  • Kenneth Pearce
August 10, 2026
America's Favorite Drug_ Coffee and Caffeine

Medical Inventions & America’s Favorite Mind-Altering Substance

Do you like it?
Read more
August 3, 2026
Waylaid in Phase III_ What to Do When the FDA Panel Questions Your Foundation

Waylaid in Phase III: What to Do When the FDA Panel Questions Your Foundation

Do you like it?
Read more
June 29, 2026
Fast track FDA approval

Drive Your Medical Invention Down the FDA Autobahn in the Passing Lane

Do you like it?
Read more
May 25, 2026
Phase 4 Clinical Trials for Medical Patents

Phase IV: It’s Not Over ‘Till It’s Over

Do you like it?
Read more
February 16, 2026
505-b-2 Advantage “Hybrid” is the Power Move in 2026.webp

The 505(b)(2) Advantage: “Hybrid” is the Power Move in 2026

Do you like it?
Read more

Patent Maestro® – Orchestrating Technology To The Patient℠

©2024-2026 Medical Patents Broker, Inc. | Sitemap | Website by Cool Jazz, LLC

Privacy Policy | Terms of Service | Directory Disclaimer & Terms | Cookie Policy | Contact